Gemcitabine
8 Inquiries
95058-81-4
Pharmaceutical Grade
99%
Any China Port
1kg/as customer's requirment
2020-06-29
API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Gemcitabine
Other Name:Cytidine,2′-deoxy-2′,2′-difluoro-;2′-Deoxy-2′,2′-difluorocytidine;LY 188011;Gemcitabine;DDFC;2′,2′-Difluoro-2′-deoxycytidine;2′,2′-Difluorodeoxycytidine;DFdC;NSC 613327;DFdCyd;Gamcitabine;Folfugem;Gemcel;GemLip;Zefei;1239668-67-7;1713284-97-9
CAS No.:95058-81-4
Molecular Formula:C9H11F2N3O4
InChIKeys:InChIKey=SDUQYLNIPVEERB-QPPQHZFASA-N
Molecular Weight:263.2
Exact Mass:263.20
EC Number:1308068-626-2
UNII:B76N6SBZ8R
DSSTox ID:DTXSID3040487
NCI Thesaurus Code:C66876
Color/Form:Crystals from water, pH = 8.5
ATC Code:L01BC05|L - Antineoplastic and immunomodulating agents
HScode:29349990
Categories:
Characteristics-
PSA:
108
XLogP3:-1.5
Appearance:Solid
Density:1.8±0.1 g/cm3
Melting Point:72.6 °C
Boiling Point:482.7°C at 760 mmHg
Flash Point:236.8±31.5 °C
Refractive Index:1.652
Water Solubility:H2O: soluble
Vapor Pressure:1.7X10-9 mm Hg at 25 deg C (est)
Toxicity:LD10 i.v. in rats: 200 mg/m2 (Abbruzzese)
Specific rotation:365 +425.36°; D +71.51°
PKA:3.6None
Henrys Law Constant:Henry's Law constant = 1.7X10-17 atm-cu m/mol at 25 °C (est)
Dissociation Constants:3.6|pKa1 = 5.27 (imine); pKa2 = 11.24 (alcohol) (est)
Experimental Properties:White to off-white solid. MW: 299.66. Soluble in water, slightly soluble in methanol, and practically insoluble in ethanol and polar solvents. /Hydrochloride/|Hydroxyl radical reaction rate constant = 4.0X10-13 cu cm/molec-sec at 25 °C (est)|Ozone reaction rate constant = 1.7X10-16 cu cm/molec-sec at 25 °C (est)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Acute toxicity - Category 4, Dermal
Skin irritation, Category 2
Eye irritation, Category 2
Germ cell mutagenicity, Category 1B
Carcinogenicity, Category 2
Reproductive toxicity, Category 1B
Specific target organ toxicity â repeated exposure, Category 1
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H312 Harmful in contact with skin
H315 Causes skin irritation
H319 Causes serious eye irritation
H340 May cause genetic defects
H351 Suspected of causing cancer
H360 May damage fertility or the unborn child
H372 Causes damage to organs through prolonged or repeated exposure
H411 Toxic to aquatic life with long lasting effects
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P203 Obtain, read and follow all safety instructions before use.
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P273 Avoid release to the environment.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P317 Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
P332+P317 If skin irritation occurs: Get medical help.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
P391 Collect spillage.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.
Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.
Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History8 Inquiries
Country Product Purchase Quantity Date Posted 
India
Gemcitabine
2 KG Dec 8, 2025
India
GEMCITABINE
100 G Jul 28, 2025
India
Gemcitabine
5 KG Jul 22, 2025 
Philippines
Gemcitabine
1 G Sep 9, 2025
Philippines
Gemcitabine
1 G Aug 18, 2025
India
Jemcitabin
20.00 KG Apr 7, 2024
India
Gemcitabine Base (2'-Deoxy-2',2'-difluorocytidine)
50 KG Dec 12, 2025
India
Gemcitabin
500.00 KG Dec 26, 2024 Post an enquiry for this product